Sat, Apr 19, 2014, 9:13 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Questcor Pharmaceuticals, Inc. (QCOR) Message Board

  • holidayinnandout holidayinnandout Mar 27, 2013 8:29 AM Flag

    Lazard Capital Has A Buy Rating and $74 Price Target

    We're not just pulling numbers out of the air....QCOR is a cash cow with no debt.
    Maxdad thinks that Lazard is too conservative, and the price target should be higher.
    Simple math can suggest that QCOR is going to double or triple (plus).
    When the stock is selling at $100, then $150 is not too far away.
    (plus giving a big dividend and buying back stock)
    QCOR hired a new mergers and acquisitions banker guy in January, and he was not hired for his chemist skills..
    QCOR bought the entire store (BioVectra) when they purchased the company that manufactures their wonderful drug, Acthar.
    Lazard Capital stated this $74 price target on December 31,2012 at wall street cheat sheet...

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
76.95-1.51(-1.92%)Apr 17 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.